Literature DB >> 23072328

Cervical cancer screening measures need to evolve to continue to tell the story.

Mona Saraiya, Meg Watson, Vicki B Benard.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23072328      PMCID： PMC5555393          DOI： 10.1089/jwh.2012.3994

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN： 1540-9996            Impact factor:   2.681


× No keyword cloud information.
  10 in total

Review 1.  American Cancer Society guideline for the early detection of cervical neoplasia and cancer.

Authors:  Debbie Saslow; Carolyn D Runowicz; Diane Solomon; Anna-Barbara Moscicki; Robert A Smith; Harmon J Eyre; Carmel Cohen
Journal:  CA Cancer J Clin       Date:  2002 Nov-Dec       Impact factor: 508.702

2.  ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995).

Authors: 
Journal:  Obstet Gynecol       Date:  2003-08       Impact factor: 7.661

3.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

4.  Cervical cancer screening among foreign-born women by birthplace and duration in the United States.

Authors:  Jennifer Tsui; Mona Saraiya; Trevor Thompson; Achintya Dey; Lisa Richardson
Journal:  J Womens Health (Larchmt)       Date:  2007-12       Impact factor: 2.681

Review 5.  Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis.

Authors:  M Kyrgiou; G Koliopoulos; P Martin-Hirsch; M Arbyn; W Prendiville; E Paraskevaidis
Journal:  Lancet       Date:  2006-02-11       Impact factor: 79.321

Review 6.  The Behavioral Risk Factors Surveillance System: past, present, and future.

Authors:  Ali H Mokdad
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

7.  Cervical cancer screening in the United States, 1993-2010: characteristics of women who are never screened.

Authors:  Han-Yang Chen; Courtenay L Kessler; Naoyo Mori; Suneet P Chauhan
Journal:  J Womens Health (Larchmt)       Date:  2012-08-08       Impact factor: 2.681

8.  The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.

Authors:  Philip E Castle; Julia C Gage; Cosette M Wheeler; Mark Schiffman
Journal:  Obstet Gynecol       Date:  2011-12       Impact factor: 7.661

9.  Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-06-19       Impact factor: 25.391

10.  Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.

Authors:  Wendy A Leyden; M Michele Manos; Ann M Geiger; Sheila Weinmann; Judy Mouchawar; Kimberly Bischoff; Marianne Ulcickas Yood; Joyce Gilbert; Stephen H Taplin
Journal:  J Natl Cancer Inst       Date:  2005-05-04       Impact factor: 13.506
  10 in total
  1 in total

1.  Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Vicki B Benard; Meg Watson; Mona Saraiya; Rhea Harewood; Julie S Townsend; Antoinette M Stroup; Hannah K Weir; Claudia Allemani
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.